Semaglutide, a GLP-1 receptor agonist (RA), was associated with a significantly lower risk for adult-onset epilepsy in patients with diabetes than other glucose-lowering drugs (GLDs). Notably, this ...
Background Metformin demonstrates antiepileptogenic (primary prevention) and antiseizure (symptom control) properties in ...
NEW YORK (Reuters Health) - Monitors that continuously measure sugar levels under the skin can alert diabetics when levels fall too low during sleep and awaken them before a seizure occurs, according ...
GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Semaglutide was associated with the strongest risk reduction. Epilepsy is an underrecognized ...
High blood pressure and diabetes are often called "silent" conditions for a reason. Many people live with them for years without obvious symptoms, assuming everything is under control. But when blood ...